Work

A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone

Year: 2006

Type: article

Study design: Clinical Trial

Source: European Journal of Nuclear Medicine and Molecular Imaging

DOI: 10.1007/s00259-005-0010-5

Authors: J. M. O’Sullivan, A. R. Norman, V. R. McCready, G. Flux, F. M. Buffa, B. Johnson, J. Coffey, G. Cook, J. Treleaven, A. Horwich, R. A. Huddart, C. C. Parker, D. P. Dearnaley

Institutions: Queen's University Belfast, Belfast City Hospital, Royal Marsden NHS Foundation Trust

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G3653868248, RADIONUCLIDE THERAPY OF SKELETAL METASTASES FROM CANCER

OpenAlex ID: W2038702908

FWCI: 0.507

Cites: 36

Cited by: 23

Related to: 10